Delek US Holdings, Inc.
DK NYSE Petroleum Refining Financials FY2016βFY2025
What Delek US Holdings, Inc. does
No business description yet.
- Legal name
- Delek US Holdings, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Accession Β· CIK
- 0001628280-26-012664
0001694426
Revenue and margins
Delek US Holdings, Inc. had $10.7B of revenue in fiscal 2025, down 9.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $6.3M in fiscal 2025, 0.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Delek US Holdings, Inc. returned $62.0M to shareholders in fiscal 2025, 984% of free cash flow. The diluted share count fell 5.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Delek US Holdings, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $857M | $841M | $822M | $736M | $626M |
| Debt incl. finance leases | $2.2B | $3.1B | $2.6B | $2.8B | $3.3B |
| Net debt / EBITDA | 5.9x | 3.0x | 3.0x | β | 3.8x |
| Debt / equity | 2.2x | 2.9x | 2.7x | 4.8x | 5.9x |
| Interest coverage | β1.9x | 19.6x | 4.0x | β | β |
| Current ratio | 1.0x | 1.2x | 1.0x | 0.9x | 0.8x |
| Quick ratio | 0.6x | 0.7x | 0.6x | 0.6x | 0.5x |
| Total assets | $6.8B | $8.2B | $7.2B | $6.7B | $6.8B |
| Total liabilities | $5.8B | $7.1B | $6.2B | $6.1B | $6.3B |
| Shareholders' equity | $1.0B | $1.1B | $960M | $575M | $547M |
| Net debt (β = net cash) | $1.4B | $2.2B | $1.8B | $2.0B | $2.6B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 6 / 9 | 7 / 9 | 6 / 9 | 2 / 9 | 6 / 9 | 8 / 9 | 5 / 9 | 2 / 9 | 5 / 9 |
| Accruals ratio | β13.5% | β0.7% | β3.8% | β4.1% | β5.0% | β7.7% | β2.2% | β12.9% | β7.1% | β8.3% |
| Altman Z'' | 2.17 | 1.08 | 2.61 | 1.97 | 0.13 | 0.23 | 1.24 | 0.57 | β0.68 | β0.20 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $4.2B | $7.3B | $10.2B | $9.3B | $7.3B | $10.6B | $19.8B | $16.5B | $11.9B | $10.7B |
| Net interest income | β | β | β | β | β$126M | β$137M | β$195M | β$318M | β | β |
| Gross profit | $31.8M | $432M | $973M | $890M | β$261M | $251M | $748M | $549M | β$43.1M | $612M |
| Operating income | β$49.2M | $180M | $612M | $492M | β$732M | β$34.7M | $458M | $245M | β$492M | $301M |
| Interest expense | $54.4M | $93.8M | $126M | $131M | $129M | $18.1M | $23.4M | $61.4M | β | β |
| Pretax income | β$391M | $299M | $486M | $403M | β$767M | β$137M | $322M | $16.6M | β$706M | $38.9M |
| Income tax | β$172M | β$29.2M | $102M | $71.7M | β$194M | β$42.0M | $56.4M | β$3.0M | β$108M | β$6.8M |
| Net income | β$154M | $289M | $340M | $311M | β$611M | β$128M | $257M | $19.8M | β$560M | β$22.8M |
| Diluted EPS | β$2.49 | $4.00 | $3.95 | $4.06 | β$8.31 | β$1.73 | $3.59 | $0.30 | β$8.77 | β$0.38 |
| Diluted shares | 0.06B | 0.07B | 0.09B | 0.08B | 0.07B | 0.07B | 0.07B | 0.07B | 0.06B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $248M | $320M | $560M | $575M | β$283M | $371M | $425M | $1.0B | β$66.8M | $536M |
| Capital expenditure | $46.3M | $172M | $322M | $413M | $269M | $222M | $280M | $393M | $428M | $530M |
| Free cash flow | $202M | $148M | $238M | $162M | β$552M | $149M | $145M | $621M | β$495M | $6.3M |
| Depreciation and amortization | $116M | $153M | $199M | $194M | $268M | $265M | $275M | $340M | $375M | $398M |
| Stock-based compensation | $16.4M | $17.5M | $21.4M | $25.8M | $22.8M | $24.6M | $29.1M | $27.5M | $33.8M | $86.7M |
| Acquisitions | $0.0M | β$196M | $0.0M | $0.0M | $0.0M | $0.0M | $626M | $0.0M | $183M | $181M |
| Share buybacks | $6.0M | $25.0M | $365M | $178M | $1.9M | $0.0M | $64.0M | $0.0M | $0.0M | β |
| Dividends paid | $37.5M | $44.0M | $80.1M | $86.8M | $69.1M | $0.0M | $42.8M | $60.3M | $64.2M | $62.0M |
| Dividends and buybacks | $43.5M | $69.0M | $445M | $265M | $71.0M | $0.0M | $107M | $60.3M | $64.2M | $62.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $689M | $932M | $1.1B | $955M | $788M | $857M | $841M | $822M | $736M | $626M |
| Total debt | $833M | $1.5B | $1.8B | $2.1B | $2.3B | $2.2B | $3.1B | $2.6B | $2.8B | $3.2B |
| Finance lease liabilities | β | β | β | β | β | β | β | β | β | $36.7M |
| Current assets | $1.4B | $2.6B | $2.4B | $3.0B | $2.3B | $3.0B | $3.7B | $2.7B | $2.3B | $2.1B |
| Current liabilities | $935M | $2.7B | $1.7B | $2.4B | $1.9B | $3.1B | $3.1B | $2.7B | $2.5B | $2.5B |
| Inventory | $392M | $808M | $678M | $947M | $728M | $1.3B | $1.5B | $941M | $893M | $726M |
| Property and equipment, net | $1.1B | $2.1B | $2.2B | $2.4B | $2.4B | $2.3B | $2.8B | $2.7B | $2.9B | $3.3B |
| Goodwill | $12.2M | $817M | $858M | $856M | $730M | $730M | $702M | $688M | $475M | $475M |
| Intangible assets | $26.7M | $101M | $104M | $110M | $108M | $103M | $316M | $288M | $322M | $406M |
| Total assets | $3.0B | $5.9B | $5.8B | $7.0B | $6.1B | $6.8B | $8.2B | $7.2B | $6.7B | $6.8B |
| Total liabilities | $1.8B | $4.0B | $4.0B | $5.2B | $5.0B | $5.8B | $7.1B | $6.2B | $6.1B | $6.3B |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $1.2B | $2.0B | $1.8B | $1.8B | $1.1B | $1.0B | $1.1B | $960M | $575M | $547M |
| Margins | ||||||||||
| Gross margin | 0.8% | 5.9% | 9.5% | 9.6% | β3.6% | 2.4% | 3.8% | 3.3% | β0.4% | 5.7% |
| Operating margin | β1.2% | 2.5% | 6.0% | 5.3% | β10.0% | β0.3% | 2.3% | 1.5% | β4.1% | 2.8% |
| EBITDA margin | 1.6% | 4.6% | 7.9% | 7.4% | β6.4% | 2.2% | 3.7% | 3.5% | β1.0% | 6.5% |
| Net margin | β3.7% | 4.0% | 3.3% | 3.3% | β8.4% | β1.2% | 1.3% | 0.1% | β4.7% | β0.2% |
| FCF margin | 4.8% | 2.0% | 2.3% | 1.7% | β7.6% | 1.4% | 0.7% | 3.8% | β4.2% | 0.1% |
| Net interest share of revenue | β | β | β | β | β1.7% | β1.3% | β1.0% | β1.9% | β | β |
| Returns | ||||||||||
| Return on capital | β2.9% | 7.2% | 19.2% | 13.7% | β21.6% | β1.2% | 11.5% | 8.9% | β14.9% | 9.5% |
| Return on capital employed | β2.4% | 5.5% | 14.9% | 10.6% | β17.3% | β0.9% | 9.0% | 5.5% | β11.8% | 7.0% |
| Return on equity | β13.0% | 18.4% | 18.0% | 17.1% | β41.4% | β12.0% | 24.7% | 2.0% | β73.0% | β4.1% |
| Return on assets | β5.2% | 6.5% | 5.8% | 4.9% | β9.3% | β2.0% | 3.4% | 0.3% | β8.1% | β0.3% |
| Return on tangible equity | β13.4% | 27.6% | 40.2% | 35.7% | β219.2% | β70.6% | 498.3% | β | β | β |
| Growth | ||||||||||
| Revenue growth | β | 73.1% | 40.8% | β9.1% | β21.5% | 45.8% | 86.0% | β16.8% | β28.0% | β9.5% |
| Net income growth | β | β | 17.8% | β8.7% | β296.8% | β | β | β92.3% | β2,930.3% | β |
| EPS growth | β | β | β1.3% | 2.8% | β304.7% | β | β | β91.6% | β3,023.3% | β |
| FCF growth | β | β26.8% | 61.3% | β31.9% | β440.5% | β | β2.7% | 328.0% | β179.6% | β |
| Share count change | β | 16.8% | 20.0% | β11.7% | β3.9% | 0.5% | β3.3% | β8.5% | β2.3% | β5.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.1x | 1.6x | 0.9x | 1.6x | β | 5.9x | 3.0x | 3.0x | β | 3.8x |
| Debt / equity | 0.7x | 0.7x | 1.0x | 1.1x | 2.1x | 2.2x | 2.9x | 2.7x | 4.8x | 5.9x |
| Interest coverage | β0.9x | 1.9x | 4.9x | 3.8x | β5.7x | β1.9x | 19.6x | 4.0x | β | β |
| Current ratio | 1.5x | 1.0x | 1.5x | 1.3x | 1.2x | 1.0x | 1.2x | 1.0x | 0.9x | 0.8x |
| Quick ratio | 1.1x | 0.7x | 1.0x | 0.9x | 0.8x | 0.6x | 0.7x | 0.6x | 0.6x | 0.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.1% | 2.4% | 3.1% | 4.4% | 3.7% | 2.1% | 1.4% | 2.4% | 3.6% | 4.9% |
| Stock comp / revenue | 0.4% | 0.2% | 0.2% | 0.3% | 0.3% | 0.2% | 0.1% | 0.2% | 0.3% | 0.8% |
| Payouts / FCF | 21.6% | 46.7% | 186.9% | 163.3% | β | 0.0% | 73.6% | 9.7% | β | 984.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 6.0 | 7.0 | 6.0 | 2.0 | 6.0 | 8.0 | 5.0 | 2.0 | 5.0 |
| Altman Z'' | 2.2 | 1.1 | 2.6 | 2.0 | 0.1 | 0.2 | 1.2 | 0.6 | β0.7 | β0.2 |
| Accruals ratio | β13.5% | β0.7% | β3.8% | β4.1% | β5.0% | β7.7% | β2.2% | β12.9% | β7.1% | β8.3% |
Source: SEC EDGAR XBRL filings (CIK 0001694426). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.